Tier 3 · Filer Universe

Aligos Therapeutics, Inc.

ALGS · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.

Price
$6.67
+0.00%
Coverage
Tier 3
Tier 3 · Filer Universe
SEC CIK
0001799448
Liquidity rank
#4756
Observed dollar volume

Tier 3 is a directory treatment. It does not imply options, analyst estimates, or complete company-facts coverage. Missing fields stay missing.

SEC XBRL facts

FieldValuePeriod endFiling
Annual revenue$2.19M2025-12-310001193125-26-092614
Annual diluted EPS-2.452025-12-310001193125-26-092614
Quarterly revenue$0.002026-06-300001193125-26-336851
Quarterly diluted EPS-0.142026-06-300001193125-26-336851

SEC EDGAR Frames batch generated 2026-08-23T22:53:06.910Z. Frames are calendar-aligned and may not cover every filer or fiscal period.

Filings and machine access

Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract

Context paths

HealthcareNasdaqBMY · Tier 1 peerISRG · Tier 1 peerHCA · Tier 1 peerAMGN · Tier 1 peer

Provenance

IdentitySEC company tickers and Nasdaq Symbol Directory
Quote and corporate actionsYahoo Finance chart
FundamentalsSEC EDGAR Frames